NASDAQ:JUNS Jupiter Neurosciences Q2 2026 Earnings Report $2.86 -0.15 (-4.98%) Closing price 09/18/2026 04:00 PM EasternExtended Trading$2.89 +0.03 (+1.05%) As of 09/18/2026 07:42 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. ProfileEarnings HistoryForecast Jupiter Neurosciences EPS ResultsActual EPS-$5.06Consensus EPS -$3.75Beat/MissMissed by -$1.31One Year Ago EPSN/AJupiter Neurosciences Revenue ResultsActual Revenue$0.02 millionExpected Revenue$0.40 millionBeat/MissMissed by -$375.76 thousandYoY Revenue GrowthN/AJupiter Neurosciences Announcement DetailsQuarterQ2 2026Date8/14/2026TimeBefore Market OpensConference Call DateN/AConference Call TimeN/AUpcoming EarningsJupiter Neurosciences' next earnings date is estimated for Wednesday, December 2, 2026, based on past reporting schedules. Conference Call ResourcesEarnings HistoryCompany Profile Jupiter Neurosciences Earnings HeadlinesJupiter Neurosciences Shares Plunge After Nasdaq Delisting NoticeAugust 31, 2026 | rttnews.comJupiter Neurosciences, Inc.: Jupiter Neurosciences Announces Pricing of $2.0 Million Registered Direct OfferingAugust 22, 2026 | finanznachrichten.deNVDA CEO says it’s a "once-in-a-generation opportunity"NVIDIA CEO Jensen Huang calls a little-known AI niche a once-in-a-generation opportunity, and it has nothing to do with chips or ChatGPT. Huang says AI is moving off computers and into the real world, calling it the dawn of a new industrial revolution. Matt McCall, who flagged NVDA at $6 before it climbed 3,100% in six years, reveals his top pick in this emerging space.September 20 at 1:00 AM | Monument Traders Alliance (Ad)Jupiter Neurosciences stock surges Friday: What's driving the action?August 21, 2026 | msn.comJupiter Neurosciences Announces Pricing of $2.0 Million Registered Direct OfferingAugust 21, 2026 | globenewswire.comJupiter Neurosciences, Inc. Announces 1-for-75 Reverse Stock Split Effective August 6, 2026August 5, 2026 | quiverquant.comQSee More Jupiter Neurosciences Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Jupiter Neurosciences? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Jupiter Neurosciences and other key companies, straight to your email. Email Address About Jupiter NeurosciencesJupiter Neurosciences (NASDAQ:JUNS) is a clinical-stage biopharmaceutical company focused on developing therapies for neurological and neuroinflammatory disorders. The company’s research centers on reducing inflammation in the brain and central nervous system, a process implicated in conditions such as stroke, traumatic brain injury and neurodegenerative diseases. Jupiter Neurosciences’ lead product candidate is JNS101, an orally administered, brain-penetrant formulation based on curcumin, a naturally occurring compound with potential anti-inflammatory and neuroprotective properties. The company is evaluating JNS101 as a potential treatment for diseases in which neuroinflammation plays a significant role. The company’s development activities are directed toward advancing JNS101 through clinical development and establishing its safety, tolerability and therapeutic potential. Jupiter Neurosciences is headquartered in Jupiter, Florida, and serves the biopharmaceutical market through its research and drug-development programs.View Jupiter Neurosciences ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles J.B. Hunt's Stock Plunges After Market Misprices Profit WarningLennar’s Earnings Miss May Be Sending a Bigger Warning About U.S. HousingLennar's Q3 Miss Hides a Stronger Operating Story Beneath the Housing SlumpAeluma’s Selloff Could Be Setting Up Its Next Big MoveBraze Beat Expectations—Now 2 SaaS Peers Are in FocusPriced for a Pullback or More Gains? These 3 Stocks Are Testing the LimitsCoreWeave’s Vera Rubin Lead Comes Down to Speed, Power, and Scale Upcoming Earnings Cintas (9/23/2026)Costco Wholesale (9/24/2026)Micron Technology (9/30/2026)NIKE (10/1/2026)Accenture (10/1/2026)PepsiCo (10/8/2026)Delta Air Lines (10/9/2026)America Movil (10/13/2026)BlackRock (10/13/2026)Citigroup (10/13/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
